Bibliografia

Firenzuoli, F., Epifani, F., Loiacono I. (2015). Cannabis “Erba” Medica. Milano: Edra

Fortuna, L. (2006). Aromaterapia Naturopatica. Milano: Edizioni Enea

McKenna, J. (2000). Le Alternative ai Tranquillanti. Milano: tecniche Nuove

Scrimali, T. (2020). NegEnt: A cannabidiolo-based, herbal medicine. Theoretical aspects, pharmacology, clinical and research perspectives, economical and social implications. International Journal of Herbal Medicine, 8 (5): 143-151. Consultabile e scaricabile cliccando qui.

Baban, C., Khodadadi, K., Salles, EL, Costigliola, V., Yu, JC (2021). Inflammaging and Cannabinoids. Ageing Res. Rev., Ageing Research Reviews 72(1):101487 DOI: 10.1016/j.arr.2021.101487.

Bielawiec, P., Harasim-Symbor, E., Chabowski, A. (2020). Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol. Front Endocrinol (Lausanne),  4; 11:114. Doi: 10.3389/fendo.2020.00114.

Bonaccorso, S., Ricciardi A., Zangani C., Chiappini C., Schifano, F. (2019). Cannabidiol (CBD) use in psychiatric disorders: A systematic review. Neurotoxicology, Sep; 74: 282-298. Doi: 10.1016/j.neuro.2019.08.002.

Cooke, B., Ernst, E. (2000) Aromatherapy: a systematic review. Br J Gen Pract., Jun;50(455):493-6.

Della Rocca, G., Di Salvo, A. (2020). Hemp in Veterinary Medicine: From Feed to Drug. Front Vet Sci, Jul 28;7:387. Doi: 10.3389/fvets.2020.00387.

Firenzuoli, F., Epifani, F., Loiacono I. (2015). Medical “Weed” Cannabis. Milan: Edra.

Fortuna, L. (2006). Naturopathic Aromatherapy. Milan: Enea Editions.

Gattefossé, RM (1937). Aromathérapie – les huiles essentielles hormones végétales. Paris: Librairie des Sciences Girardot.

Kasman, A.M., Hriday P., Bhambhvani, H.P., Wilson-King, G., Michael L. Eisenberg, M.L. (2020). Sexual Medicine 8 (4). Doi:10.1016/j.esxm.2020.06.009.

Koo, M. (2017). A bibliometric analysis of two decades of aromatherapy research. Published online 2017, Jan 18.

Martin, L.J., Banister, S.D., Bowen, M.T. (2021). Understanding the complex pharmacology of cannabidiol: Mounting evidence suggests a common binding site with cholesterol. Pharmacological Research, Volume 166, April 2021, 105508.

McKenna, J. (2000). Alternatives to Tranquilisers. Milan: New Techniques.

Nagarkatti P., Pandey, R., Rieder S.A., Hegde VL, Nagarkatti M.(2009). Cannabinoids as novel anti-inflammatory drugs. Future Med. Chem., 1:1333-49.

Nguyen, L.C., Yang, D., Nicolaescu, V. (2022). Cannabidiol inhibits Sars-Cov-2 replication though induction of the host ER stress and innate immune response. Sciences Advances, Volume 8, Issue 8.

Nichols, J.M., Kaplan, B.L.F. (2020). Immune Responses Regulated by Cannabidiol. Cannabis Cannabinoid Res, Feb 27;5(1):12-31. Doi: 10.1089/can.2018.0073.

Perry, N., Perry, E. (2006). Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives. CNS Drugs, Vol. 20, Issue 4.

Peyravian, N., Deo, S., Daunert, S, Jimenez, J-J. (2020). Cannabidiol as a Novel Therapeutic for Immune Modulation. Immunotargets Ther., Aug 18, 9: 131-140. Doi: 10.2147/ITT.S263690.

Price, S. Price, L. (2012). Aromatherapy for Health Professional. London: Elsevier.

Rojas-Valverde, D. (2021). Potential Role of Cannabidiol on Sports Recovery: A Narrative Review. Front Physiol, Aug 3;12:722550. Doi: 10.3389/fphys.2021.722550.

Scrimali, T (2008). Entropy of Mind and Negative Entropy a Cognitive and Complex Approach to Schizophrenia and its Therapy. London: Karnac Books.

Scrimali, T. (2020). NegEnt: A cannabidiol-based, herbal medicine. Theoretical aspects, pharmacology, clinical and research perspectives, economical and social implications. International Journal of Herbal Medicine, 8 (5): 143-151.

Scrimali, T. (2022). NegEnt: Cannabidiolo Liposomiale in Medicina Umana e Veterinaria. Enna: Edizioni ALETEIA Publisher. Su Amazon Libri.

Scrimali, T. (2023). Safety and Tolerability of NegEnt, a New Botanical Product Based on Liposomal Cannabidiol: A Case Series Report. Journal of Nutraceuticals and Food Science. Vol.8 No.1: 08.

Sheriff, T. Lin, M-J., Dubin, D., Khorasani, H. (2020). The potential role of cannabinoids in dermatology. J. Dermatolog. Treat., Dec; 31(8): 839-845. Doi: 10.1080/09546634.2019.1675854.

Stanley, C.P., Hind, W.H., O’Sullivan, S.O.(2013). Is the cardiovascular system a therapeutic target for cannabidiol? Br J Clin Pharmacol, Feb;75(2):313-22. Doi: 10.1111/j.1365-2125.2012.04351.x.

Vasudevan K, Stahl V. Cannabinoids infused mouthwash products are as effective as chlorhexidine on inhibition of total-culturable bacterial content in dental plaque samples. J Cannabis Res. 2020;2(1):20. doi:10.1186/s42238-020-00027-z.

WHO, (2018). CANNABIDIOL (CBD) Critical Review Report. Expert Committee on Drug Dependence, Fortieth Meeting, Geneva, 4-7 June 2018.

Gennaio 30, 2024

Sospeso, dal TAR Lazio, il decreto del Ministro della Salute Schillaci fino al 16 Settembre 2024

Il TAR Lazio ha rinviato la decisione, nel merito, sul Decreto Schillaci, ...
Read More
Ottobre 10, 2023

Regolamentazione del Cannabidiolo in Italia dopo il Decreto Schillaci: la posizione di Herbal Neurocare per la produzione e la vendita di NegEnt

NegEnt costituisce il punto di arrivo di un originale ed autorevole progetto scientifico italiano, allocato in ...
Read More
Maggio 16, 2023

Herbal Neurocare festeggia il suo primo anno di vendite, riducendo il prezzo di NegEnt del 12%!

Da oggi NegEnt, Cannabidiolo Liposomiale in gocce, costa 70 Euro, IVA compresa, a confezione! Questo risultato, sintono con ...
Read More
Febbraio 7, 2023

Cannabidiolo, NegEnt e Disturbo di Panico

Un Attacco di Panico è costituito da una situazione specifica, durante la quale si registra l'insorgenza improvvisa di ...
Read More
Febbraio 7, 2023

Cannabidiolo e NegEnt per Dormire Bene e Risolvere l’Insonnia

Dormine bene e riposare, per almeno sette ore a notte, costituisce, oggi, un obiettivo non sempre facilmente conseguibile, ...
Read More